Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

MR Imaging of Perinatal Brain Injury

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
Kiungo kimehifadhiwa kwenye clipboard
HaliKuajiri
Wadhamini
University of Pittsburgh

Maneno muhimu

Kikemikali

The purpose of this study is to collect and compare information from cranial ultrasounds, magnetic resonance imaging scans, neurological exam and neuropsychological assessments of children. The investigators hope that the information collected in this study will help with early screening, diagnosis and treatment of brain injury in newborns as well as identify a connection between MR imaging (MRI-magnetic resonance imaging, MRS-magnetic resonance spectroscopy) and neurodevelopmental outcome.

Maelezo

In the last two decades, major advances have been made in the clinical care of premature and term infants, including in the management of sepsis and respiratory compromise that can contribute to neurological disabilities in survivors. The incidence of classic cystic periventricular leukomalacia (PVL) has declined and a more diffuse and non-cystic pattern of cerebral white matter injury is more predominant. Although multiple pathologies occur in premature infants, the principal variety accounting for the predominance of neurodevelopmental disability is PVL. This disability in very low birth weight infants (VLBW) (< 1500 grams) includes cognitive/behavioral deficits in 25-50% and cerebral palsy in 5-10%. Neuroimaging studies of VLBW survivors suggest that the cerebral palsy is related to the focal necrotic lesions of PVL, whereas the cognitive/behavioral deficits correlate with more diffuse cerebral white matter injury. PVL is defined as damaged immature cerebral white matter with periventricular focal necrosis ("focal" component) in association with diffuse reactive gliosis and microglial activation in the surrounding white matter ("diffuse" component). Of note, PVL occurs in the late preterm infant and the term infant, particularly in cases of congenital heart disease. The pathogenesis of perinatal white matter injury is currently thought to be related to a complex interaction between maternal/fetal infection, cytokines and hypoxia-ischemia which results in both the generation of reactive oxygen specific agents (oxidative stress), apoptotic oligodendrocyte cell death, and axonal injury. In long-term survivors with PVL, neuroimaging studies often demonstrate reduced cerebral white matter volume, impaired myelination, ventriculomegaly and reduced volume in the cerebral cortex, thalamus/basal ganglia and cerebellum. In many of these long-term studies, the preterm children studies had normal cranial ultrasound. Cranial ultrasound, however, is not adequate for assessing non-cystic focal or diffuse white matter injury. To date, there are no longitudinal MR studies of preterm or congenital heart disease infants which correlate advanced neonatal MR imaging techniques with long-term neurodevelopmental outcome or advanced MR techniques performed in the childhood period.

Tarehe

Imethibitishwa Mwisho: 12/31/2019
Iliyowasilishwa Kwanza: 11/14/2013
Uandikishaji uliokadiriwa Uliwasilishwa: 12/04/2013
Iliyotumwa Kwanza: 12/10/2013
Sasisho la Mwisho Liliwasilishwa: 01/05/2020
Sasisho la Mwisho Lilichapishwa: 01/06/2020
Tarehe halisi ya kuanza kwa masomo: 03/31/2009
Tarehe ya Kukamilisha Msingi iliyokadiriwa: 02/28/2025
Tarehe ya Kukamilisha Utafiti: 11/30/2025

Hali au ugonjwa

Perinatal White Matter Brain Injury

Uingiliaji / matibabu

Device: Magnetic Resonance Imaging

Behavioral: Neurodevelopmental Testing

Awamu

-

Vikundi vya Arm

MkonoUingiliaji / matibabu
Neonates at Risk for Brian Injury
Magnetic Resonance Imaging Neurodevelopmental Testing - 18 Month
Term Neonates
Magnetic Resonance Imaging Neurodevelopmental Testing - 18 Month

Vigezo vya Kustahiki

Jinsia Inastahiki KujifunzaAll
Njia ya sampuliProbability Sample
Hupokea Wajitolea wa AfyaNdio
Vigezo

Inclusion Criteria:

- Preterm babies and neonates with congenital heart disease

- Term Neonates

Exclusion Criteria:

- Severe congenital brain malformation

- Significant chromosomal abnormality / syndrome which could confound the neurodevelopmental follow up data

- Preterm birth and congenital heart disease

- Focal neurological abnormality

- Chronic seizures

- Severe congenital brain malformation

- Significant chromosomal abnormality/ syndrome which could confound the neurodevelopmental follow up data

- Major pregnancy complication (diabetes, eclampsia)

- Sepsis

- ECMO

- Significant birth trauma and/or hypoxic ischemic injury

Matokeo

Hatua za Matokeo ya Msingi

1. Developmental Assessment [18 Months]

Administration of neurodevelopmental testing and completion of parent questionnaires regarding the child's development.

Hatua za Matokeo ya Sekondari

1. Assessment of White Matter Injury in Brain [Baseline]

MR Scan

2. Changes in White Matter Injury from Baseline [at 6 Years]

MR Scan

Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge